The frequency and characteristics of childhood acute leukemia with a 14q32 translocation [other than the t(8;14)(q24:q32)] were determined in 335 cases of newly diagnosed acute lymphoblastic leukemia (ALL) and 105 cases of acute nonlymphoblastic leukemia (ANLL). Ten children, representing 2.3% of the entire cohort, had this abnormality (1.5% of ALL patients and 4.8% of ANLL patients). By French-American-British (FAB) criteria, 4 cases were classified as L1,l as L2.2 as MI, 1 as M2, and 2 as M5. Remarkably, mixed-lineage expression was found in 6 of these I d cases, but in only 21 of the other 430 cases without a 14q32 translocation (P < .001). Leukemic cells from 5 of these 6 cases (4 ANLL, and 1 ALL) coexpressed CD13, a myeloid-associated antigen, arid CD2, a T-cell-EUKEMIC BLAST cells are generally thought to arise
(IgH) are located in this region.23 However, 14q32 abnormalities have also been reported in adult T-cell lymphoma/ l e~k e m i a ,~~.~~ T-cell l y m p h~m a ,~' ,~~ T-cell chronic lymphocytic leukemia (CLL),26-28 mycosis f~n g o i d e s ,~~ and, rarely, in acute nonlymphoblastic leukemia (ANLL). 30 We report here 10 children with acute leukemia and 14q32 translocations other than t(8;14)(q24;q32), which has been well-studied in Burkitt's lymphoma/leukemia. Remarkably, six of these patients had mixed-lineage characteristics. These results extend the finding of 14q32 translocations to acute mixed-lineage leukemia and suggest that an unidentified important gene may reside in this chromosomal region.
MATERIALS AND METHODS
From June 1983 to June 1988, we successfully analyzed leukemic cell karyotype and immunophenotype from 440 children with newly diagnosed acute leukemia, including 105 with ANLL and 335 with ALL. In this group, 14q32 translocations other than t(8;14)(q24;q32) were observed in five patients with ANLL (4.8%) and five with ALL (1.5%). These 10 patients are the subjects of this report. The clinical data of patients 1, 2, and 3 have been reported previously.'~" Informed consent was obtained from the patients or their parents, and these investigations were approved by the institution's Clinical Trials Review Committee.
Bone marrow smears were stained with Wright-Giemsa, periodic acid-Schiff (PAS), myeloperoxidase (MPO), Sudan black B (SBB), and alpha-naphthyl butyrate esterase (ANB). Morphologic classification followed French-American-British (FAB) criteria.'' Bone marrow samples were processed according to the method of Williams et a133; additional 24-hour cultures were also performed when samples were available. Gbanding was done by treatment with trypsin and staining with Wright stain. Chromosome abnormalities were classified according to the International System for Human Cytogenetic Nomenclature (1 985).34
Cell-surface antigens were detected by a standard indirect immunofluorescence assay' with monoclonal antibodies to lymphoid-associated antigens, including J5 (common ALL antigen [CALLA], CDlO), TI1 (CD2). T1 (CD5), T3 (CD3).
Leu-9 (CD7), B1 (CD20), and B4 (CD19), as well as myeloidassociated antigens, including MY1 (CDlS), MY4 (CD14). MY7 (CD13), MY9 (CD33). and 5F1 (CD36). After being stained, the leukemic cells were analyzed by fluorescence microscopy or with an Morphologic and cytochemical studies.
Chromosome analysis.
Immunophenotyping.
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For personal use only. on August 30, 2017. by guest www.bloodjournal.org From 14a32 TRANSLOCATIONS IN ACUTE LEUKEMIA 151 EPICS C flow cytometer equipped with a 5-W coherent laser (Coulter, Hialeah, FL). Staining of greater than 25% of the cells was considered a positive result. To demonstrate simultaneous expression of lymphoid-and myeloid-associated antigens by individual blasts, we examined cells from patients 3 and 10 with two-color immunofluorescence, using the EPICS C flow cytometer and the fluorescence isothiocyenate (F1TC)-phycoerythrin (PE) dual-immunofluorescence proto~ol.~ Normal human lymphocytes dual-labeled with Leu 3a (CD4) conjugated to FITC and Leu 2c (CD8) conjugated to PE (Simultest, Becton Dickinson, Mountain View, CA) were used to correct for fluorescent spectrum overlap. In all experiments, negative controls included irrelevant mouse Ig directly conjugated to FITC or PE. CD2 antibody conjugated to FITC (Tll-FITC) and CD13 antibody conjugated to PE (MY7-PE) (Coulter Immunology) were from commercial sources. Blast cells were also tested for surface Ig (sIg) and cytoplasmic Ig (clg), which was considered positive if greater than 10% of cells were positive. Terminal deoxynucleotidyl transferase (TdT), detected by an immunofluorescence assay, was considered positive if more than 15% of cells demonstrated nuclear fluorescence.
The classification of ANLL and ALL followed FAB criteria." Cases of ANLL were considered to have mixed-lineage expression if the leukemic cells coexpressed two or more B-lineage-associated antigens (eg, CD19, CD20, CD22, cIg, sIg), or two or more T-lineage-associated antigens (eg, CD2, CD3, CD5, CD7). Similarly, the mixed-lineage expression in ALL cases was based on the coexpression of two or more myeloid-associated antigens (eg, CD1 lb, CD13, CD14, CD33, CD36).
High molecular weight (mol wt) DNA was probed as described previously?," BamHI, EcoRI, and HindIII digestions were used to analyze IgH genes; the probe consisted of a 3.4-kilobase (kb) EcoRIIHindIII fragment of the joining region (JH) that detects an 18-kb BamHI, a 17-kb EcoRI, and a 12-kb HindIII germ line fragment.I5 BomHI digestions were also probed with a 2.5-kb K light chain gene fragmentJ6 that recognizes a 12-kb germ line fragment. TCR @-chain gene rearrangements were analyzed after BamHI, EcoRI, or Xba digestion of high mol wt DNA by probing with pB400, a 0.4-kb cDNA containing sequences for C@,.37 y-Chain gene rearrangements were analyzed after EcoRI digestion using pJyl .38 DNAs were labeled by the oligolabeling procedure and generally had specific activities of 5 to 10 x 10' cpmlpg. High stringency conditions were used for hybridization and washing. The filters were exposed to Kodak XAR film (Eastman Kodak, Rochester, NY) in the presence of intensifying screens. All experiments included control DNA containing germline arrangements of the Ig and TCR genes. Gene rearrangement was considered to be present if an abnormal band was identified with one or more restriction enzyme digestion.
CIassifcation of acute mixed-lineage leukemia.
Southern blot analysis.
RESULTS
The pertinent clinical and laboratory features of the 10 cases with 14q32 translocation are shown in Table 1 . The five boys and five girls ranged in age from 2 to 18 years (median, 5.9 years). By FAB criteria, cases 1 to 5 were classified as ANLL (M1 in 2 cases, M2 in 1, and M 5 in 2) and cases 6 to 10 as ALL (L1 in 4 cases and L2 in 1). Although the three cases with M I or M2 leukemia had positive MPO, the reactivity was low (less than 15%) in two of them. Initial central nervous system leukemia was present in patient 5 and a mediastinal mass in patient 10. Patients 1 through 5 received myeloid-directed induction treatment; two (nos. 3 and 4) failed to respond to the initial therapy. Patient 3 subsequently achieved a complete remission with lymphoiddirected induction therapy. Prolonged remissions have been maintained in patient 1 (30+ months), who underwent syngeneic bone marrow transplant in first remission, and in patient 3 (45+ months). All five patients with FAB-defined ALL attained a complete remission after lymphoid-directed induction therapy and remain disease-free for 1 + to 56 + months.
Lineage-associated characteristics in these cases are shown in Table 2 . Four of the five patients with ANLL (nos. 1 through 4) had leukemic cells that expressed myeloidassociated (CDl3) and more than two T-lymphoid-associated antigens; three of these cases had positive TdT, and one also eKpressed the CDlO antigen. None of the FAB-defined ANLL cases expressed B-lineage-associated markers. The overlap in the percentage of leukemic cells expressing myeloidor lymphoid-associated antigen suggested that some leukemic cells in these cases coexpressed antigens of both lineages. Dual-color immunofluorescence testing of blast cells from patients 3 and 10 showed coexpression of CD2 and CD13 antigens in 23% and 47% of the cells examined, respectively. The IgH gene was in germline configuration in all three cases examined, and the TCR-/3 gene was rearranged in two.
Leukemic cells from 2 of the 5 patients (nos. 9 and 10) who met the FAB criteria for ALL expressed two or more myeloid-associated antigens. The remaining three cases had typical pre-B-cell ALL phenotype. Molecular genetic testing of one patient with mixed-lineage expression disclosed no evidence of Ig or TCR gene rearrangement.
Among the 430 cases without a 14q32 translocation, we have identified 2 1 cases with mixed-lineage expression. Thus, the frequency of mixed-lineage leukemia in cases with 14q32 translocations (6 of 10) is significantly higher than that in cases lacking a 14q32 translocation (P i .001). In this series, the overall incidence rates of mixed-lineage leukemia with a predominance of ANLL and ALL markers were 13.3% and 3.8%, respectively. Furthermore, the frequency of the 14q32 abnormality in ANLL w-ith mixed-lineage immunophenotype was 28.5% (4 of 14); in all other ANLL cases it was 1.1% (1 of 19). By contrast, the frequency of the 14q32 abnormality in cases of ALL with mixed-lineage leukemia was 15.4% (2 of 13), compared with 0.99% (3 of 322) in other cases.
Chromosomal findings of the 10 cases are listed in Table 3 . Reciprocal translocations involving 14q32 were identified in eight cases; the breakpoints of reciprocal chromosomes were lq23, 2q24-q31, 4q21, 6q23-q25, 7~1 5 , 8ql1, 8q21, and 12q13. The breakpoint involving 7p15 was found in two patients (nos. 2 and 6). Balanced reciprocal translocations in six cases are shown in Fig 1. None of the cases had t ( 11;14) or t( 14;18), known nonrandom translocatons in non-Hodgkin's lymphoma.
DISCUSSION

Although several cases with features of both the T-cell and myeloid lineages have been
no consistent chromosome abnormalities have been identified. This study suggests that translocations involving 14q32 may be one of the nonrandom chromosomal abnormalities in acute mixed- recently reported in T-cell m a l i g n a n c i e~~~~~~~~~~~~ but is rare in ANLL. 30 We now extend these findings to cases with mixed-lineage features.
Of the four cases of ANLL expressing T-cell-associated surface antigens, two had low levels of MPO positivity, a finding we have previously r e p~r t e d .~' Two of five cases with ALL by FAB criteria expressed two or more myeloid-associated antigens; one case had T-cell and myeloidassociated antigens, and the other had B-lineage-associated (pre-B-cell type) and myeloid-associated antigens. Notably, IgH gene rearrangement was not observed in the four cases of mixed-lineage leukemia examined, although the IgH gene is contained in the 14q32 band.
Three of five ALL cases with 14q32 translocation had a pre-B-cell phenotype. Although some cases with 14q+ have been reported in this form of ALL,42,43 14q32 translocations other than t(8;14)(q24;32) are rare.44 These three cases had low initial leukocyte counts (less than 10 x 109/L) and a favorable age at diagnosis (3 to 5 years); they remain free of Exchanged chromosomes in translocations involving 14q32 were identified in eight cases. The t(7;14) seen in patient 2 has been reported in T-cell leukemic cells in children,46 patients with ataxia telangiecta~ia?~ and rarely in T lymphocytes from normal individ~als.~' Although the TCR y-chain is located in one of the breakpoints, 7p15, the y-chain gene was not rearranged in this case, nor was the IgH gene. Interestingly, the t(4;14;7) seen in patient 6 was considered to be a variant type of the t(7;14). Thus, the t(7;14) may be a nonrandom translocation in childhood acute leukemia. The t(12;14) seen in patient 10 has been reported in adult T-cell leukemia.24 Abnormalities similar to the t( 1;14) in patient 1 and the t(8;14)(q?21.3;q32) in patient 2 have been reported in non-Hodgkin's l y m p h~m a .~~.~' Patient 9 had a t(9;22) and a t(8;14)(ql l;q32), which has been reported in childhood ALL.5',52 Since the t(9;22) has been reported in cases of acute mixed-lineage le~kemia,~.' 2~' the mixed-lineage expression in this case may also be related to this translocation.
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Although 14q-t or t(5;14)(q?;q32) has been reported in ALL patients presenting with hypere~sinophilia,~~.~~ neither abnormality was identified in this study.
The reason for the mixed-lineage expression among cases with 14q32 translocation is unknown. The lack of rearrangement of the IgH gene in our mixed-lineage cases suggests that the breakpoints of 14q32 did not involve the J, region of the IgH gene. Nevertheless, it is still possible that the enhancer or promotor of the IgH gene may be involved in the development of these cases. Another possibility is the involvement of a putative ~n c o g e n e~~. '~ or the proto-oncogene (AKT-15' or ELK-259) located in the 14q32 region. Some of these genes have been localized to a region centromeric to the IgH gene which is located a t 14q32.3. Finally, a myeloid or T-lymphoid-associated gene, or both may reside in the 14q32 region. Further molecular studies are needed to clarify this issue.
